Abstract

Federal prosecutors have charged four Genentech employees with conspiracy to steal the firm’s trade secrets. Led by principal scientist Xanthe Lam, the group allegedly took proprietary information covering the cystic fibrosis treatment Pulmozyme and cancer drugs Rituxan, Herceptin, and Avastin. Prosecutors claim the four gave the information to the Taiwanese pharmaceutical maker JHL Biotech to develop competing biosimilars. All four have pleaded not guilty.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call